Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Candidate shows antidepressant signal in difficult to treat depression
7+ hour, 20+ min ago (195+ words) Australian company Actinogen Medical has announced that results from its Phase 2 proof-of-concept trial of XANAMEM (emestedastat) have been published in the British Journal of Psychiatry, reporting meaningful antidepressant activity in a population described as difficult to treat. The randomised, double-blind,…...
Viagra May Reduce Cancer Metastasis, Study Shows
2+ hour, 17+ min ago (695+ words) Mirage News Viagra was originally developed to treat high blood pressure and chest pain caused by reduced blood flow to the heart, but over the past three decades it has become the world's best-known therapy for erectile dysfunction. In the…...
Frontiers in T1D Cure Call for Consolidated Researchers
5+ hour, 33+ min ago (392+ words) The Frontiers in T1D Cure 2026 call, launched by Fundación DiabetesCERO, provides two research grants of €100,000 each to support innovative biomedical research aimed at finding a cure for type 1 diabetes (T1D). The programme funds preclinical and translational research led by experienced researchers at…...
Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months
1+ day, 11+ hour ago (43+ words) Veradermics Incorporated on Wednesday released topline results from an open-label Phase 2 trial evaluating its experimental VDPHL01 in women with mild-to-moderate pattern hair loss. The company said the treatment produced consistent hair growth, demonstrated an early onset of activity, and......
Verismo Secures CLDN6 Target, Expands Solid Tumor CAR-T Pipeline
11+ hour, 44+ min ago (228+ words) Published 21 Jul.2026 08:07(KST) HLB Innovation's U.S. subsidiary, Verismo Therapeutics, announced on July 21 that it has secured a novel solid tumor-targeted binder through research collaboration with the University of Pennsylvania (UPenn) and will expand its next-generation KIR-CAR platform-based solid tumor pipeline. Verismo…...
Yukon gov't working to add new cystic fibrosis medication to its drug plan
12+ hour, 19+ min ago (323+ words) The Yukon government is looking into a new drug that one advocate says would improve the lives of Yukoners living with cystic fibrosis. Cystic fibrosis is a genetic disease where the body creates thick, sticky mucus which, untreated, could lead…...
Pennington Biomedical earns fifth NIH renewal for nationally recognized Nutrition Obesity Research Center, one of only 11 in the nation
15+ hour, 41+ min ago (148+ words) image: LSU’s Pennington Biomedical Research Center in Baton Rouge, La. view more LSU’s Pennington Biomedical Research Center has received a five-year, $5.66 million renewal of its Nutrition Obesity Research Center (NORC) grant from the National Institute of Diabetes and Digestive and…...
Shareable Social Media Graphics on mRNA Vaccines - Public Health Communications Collaborative
16+ hour, 28+ min ago (212+ words) mRNA vaccines are back in the news, as the FDA Advisory Committee recently announced its support for the Moderna mRNA flu vaccine review. These ready-to-share social media graphics are designed to help communicate accurate, evidence-based information about mRNA vaccines. Share…...
Massive Bio Partners With FOMAT to Expand Cancer Patient Prescreening for Clinical Trial Access
18+ hour, 52+ min ago (660+ words) Yahoo Finance Oops, something went wrong U.S. markets close in 3h 24m Massive Bio Partners With FOMAT to Expand Cancer Patient Prescreening for Clinical Trial Access AI-driven oncology company joins forces with the nation's largest Embedded Research Organization to connect more cancer patients…...
Tell Us The Wellness Trend That Flopped For You And What You Did That Actually Helped
18+ hour, 28+ min ago (16+ words) Please share the popular health trends that didn't work for you, and the ones that did!...